Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Central nervous system ion channels are transmembrane proteins forming pores in neuronal cell membranes, enabling rapid and selective passage of ions such as sodium (Na⁺), potassium (K⁺), calcium (Ca²⁺), and chloride (Cl⁻)[1][7][9]. They are essential for establishing and shaping electrical signals in the CNS, driving neuronal excitability, synaptic transmission, and neurotransmitter release[3][7]. They are categorized by gating mechanism—voltage-gated, ligand-gated, and mechanically-gated types—with additional subdivision by ion selectivity (e.g., sodium, potassium, calcium, chloride channels)[1][3][5][7][9]. CNS ion channels are validated therapeutic targets in numerous neurological and psychiatric diseases such as epilepsy, pain, anxiety, and neurodegenerative disorders[4][6][8]. Diverse drug classes—including local anesthetics, anticonvulsants, antidepressants, and anxiolytics—act on these targets either by inhibiting, modulating, or enhancing ion channel activity[2][4][8]. However, challenges in drug discovery include achieving channel subtype and tissue selectivity to avoid off-target effects and adverse events[4][8]. Notably, “CNS ion channels” is not itself a single molecular target but a collective term encompassing many specific ion channels in the CNS, such as voltage-gated sodium channels (Nav), potassium channels (Kv), calcium channels (Cav), and ligand-gated channels (including GABA_A and NMDA receptors)[1][2][4][6]. Therefore, for drug development or detailed research, referencing specific channel subtypes (e.g., Sodium channel protein type 1 subunit alpha/SCN1A, Kv1.1/KCNA1) is recommended rather than the generic “CNS ion channel”.
Inhibition/blockade of ion flux (e.g., sodium or calcium channel blockers) Enhancement/opening of specific channels (e.g., potassium channel openers) Modulation of ligand binding sites (e.g., benzodiazepines on GABA_A receptors) State-dependent blockade (preferentially bind open/inactivated states) Alteration of gating kinetics
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Central nervous system ion channel (CNS ion channel).